Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects—and costs—without jeopardizing survival.
WSJ.com: What's News US, Wall Street Journal
Sun, 06/03/2018 - 11:33am
Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects—and costs—without jeopardizing survival.